The appearance of facial wrinkles, lines, or folds is a natural phenomenon during aging. Different scales help classify wrinkles objectively, such as the Facial Wrinkle Scale. Others help classify patients' subjective perspectives, like the Face-Q questionnaire. The application of Botulinum Toxin is the most performed non-surgical aesthetic procedure in the world to treat facial expression lines. The present study aims to compare the efficacy of onabotulinum toxin-A (BOTOX®) and prabotulinum toxin-A (NABOTA®) to treat expression lines in the upper third of the face, based on objective and subjective follow-up, using the FWS scale and FACE-Q questionnaire, respectively.
Age range
25 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in subjective evaluation of botulinum toxin between groups
Timeframe: Pre treatment
Change in subjective evaluation of botulinum toxin between groups
Timeframe: On day 7
Change in subjective evaluation of botulinum toxin between groups
Timeframe: On day 30
Change in subjective evaluation of botulinum toxin between groups
Timeframe: On day 120
Change in objective evaluation of botulinum toxin between groups
Timeframe: Pretreatment
Change in objective evaluation of botulinum toxin between groups
Timeframe: On day 7
Change in objective evaluation of botulinum toxin between groups
Timeframe: On day 30
Change in objective evaluation of botulinum toxin between groups
Timeframe: On day 120